TY - CHAP M1 - Book, Section TI - Remote Monitoring and Home Hemodialysis A1 - Wentworth, Danielle A1 - Abdel-Rahman, Emaad M. A2 - Knicely, Daphne H. A2 - Abdel-Rahman, Emaad M. A2 - Greenberg, Keiko I. PY - 2021 T2 - Handbook of Home Hemodialysis AB - Patients with end-stage kidney disease (ESKD) undergoing home hemodialysis (HHD) make up only a small fraction of all patients receiving renal replacement therapy (RRT) in the United States. According to the United States Renal Data System (USRDS), there were 106,915 incident in-center hemodialysis (HD) patients (88.5% of all incident dialysis patients) compared to only 488 HHD patients (0.4%) in 2017.1 Among prevalent patients at the end of 2017, there were 458,125 in-center HD patients (87.5%) and only 9460 HHD patients (1.8%), with the remainder of ESKD patients utilizing peritoneal dialysis (PD) or undergoing renal transplant.1 Given the low utilization of HHD, there has been significant interest in identifying the barriers that preclude greater use of this treatment modality. Some of the most prominent factors include patient and/or care partner misconceptions about level of difficulty, lack of confidence in performing HHD, concerns about troubleshooting issues that arise during home therapy, and feelings of isolation from medical providers.2 However, the overall risks to patients undergoing HHD are very low, with one study citing a procedure-related adverse event rate of 0.06 per 1000 HHD treatments, and overall death rate of 0.0085 per 1000 treatments.3 SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1178970152 ER -